These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Some thoughts on the generic equivalency debate. Berry FB Med Times; 1971 Sep; 99(9):199-201. PubMed ID: 5170858 [No Abstract] [Full Text] [Related]
6. FDA approvals. New drugs, new uses. Rodman MJ RN; 1991 Mar; 54(3):61-8. PubMed ID: 2003204 [No Abstract] [Full Text] [Related]
7. Two new efforts to inform patients about drugs launch a post-PPI era. Med World News; 1982 Sep; 23(20):8-9. PubMed ID: 11645760 [No Abstract] [Full Text] [Related]
8. FDA urged to establish "provisional approval" system for new drugs. Odne MA; Jeffrey LP Hosp Formul; 1976 Jul; 11(7):346. PubMed ID: 1026691 [No Abstract] [Full Text] [Related]
9. American Academy of Pediatrics. Committee on drugs. Drug testing in children: FDA regulations. Pediatrics; 1969 Mar; 43(3):463-5. PubMed ID: 5818481 [No Abstract] [Full Text] [Related]
10. AMA drug evaluations. A praiseworthy venture. Robinson RR; Clapp JR Arch Intern Med; 1971 Jul; 128(1):147-8. PubMed ID: 5088410 [No Abstract] [Full Text] [Related]
11. The history and contemporary challenges of the US Food and Drug Administration. Borchers AT; Hagie F; Keen CL; Gershwin ME Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043 [TBL] [Abstract][Full Text] [Related]
13. Year-end review shows 23 new drugs approved, 14 important biologic licensing actions taken by FDA. Clin Pharm; 1991 Mar; 10(3):167-8. PubMed ID: 2040121 [No Abstract] [Full Text] [Related]
14. FDA to fast-track recombinant drugs. Am Pharm; 1981 Feb; NS21(2):19. PubMed ID: 7211687 [No Abstract] [Full Text] [Related]
15. The FDA new drug approval process. Gifford RW Conn Med; 1980 May; 44(5):309-11. PubMed ID: 7379526 [No Abstract] [Full Text] [Related]
16. AIHP Kremers Award Address 2006. Pharmacovigilance and the missing denominator: the changing context of pharmaceutical risk mitigation. Daemmrich A Pharm Hist; 2007; 49(2):61-75. PubMed ID: 18368740 [No Abstract] [Full Text] [Related]
17. Medicine strengthens its voice at AMA annual meeting. Engelbrecht JA; Carpenter MS S D Med; 2006 Aug; 59(8):363. PubMed ID: 16941857 [No Abstract] [Full Text] [Related]
18. FDA announces initiative to curb counterfeit drugs. FDA Consum; 2003; 37(5):6. PubMed ID: 14666893 [No Abstract] [Full Text] [Related]
19. Advantages of universal coding and classification system for drugs. Drug classification activities of the American Medical Association. Seitner PG Am J Hosp Pharm; 1966 Feb; 23(2):88-92. PubMed ID: 5952046 [No Abstract] [Full Text] [Related]
20. New drugs and the Kefauver-Harris amendment. Krantz JC J New Drugs; 1966; 6(2):77-9. PubMed ID: 5917906 [No Abstract] [Full Text] [Related] [Next] [New Search]